from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0642c/mmaA4

LFCtreatmentdescriptionclass of inhibitor

-0.903

Amikacinug/mL Amikacintranslation

-0.508

Cap5-10ug/mL Capreomycintranslation

-1.021

Rox10-50 ug/mL Roxithromycintranslation

0.623

SM2-5 ug/mL Streptomycintranslation

-0.598

Tet5-10 ug/mL Tetracyclinetranslation

-0.711

Rif0.2-5ug/mL Rifampicintranscription

-0.170

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.256

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.437

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.286

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.401

Clofazimine10-13 ug/mL Clofaziminerespiration

0.539

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.589

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.626

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.002

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.604

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.017

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.073

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.541

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.030

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.183

KCN5-20 ug/mL Potassium cyaniderespiration

0.196

NaN30.2-2 mM Sodium aziderespiration

0.206

Nigericin50 uM Nigericinrespiration

-1.173

TRC10-150 ug/mL Triclosanrespiration

-1.581

TRZ10-25 ug/mL Thioridazinerespiration

-1.247

Valinomycin0.5-10 uM Valinomycinrespiration

0.989

ZnSO42 mM ZnSO4respiration

-0.017

menadione6-10 ug/mL Menadionerespiration

0.023

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.998

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.477

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.116

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.288

NRP_1Non-replicating persistence stage 1dosRassociated

0.973

Amp0.2mg/mL AmpicillincellWall

0.812

Cephalexin20-100 ug/mL CephalexincellWall

0.925

Cerulenin0.32-5 ug/mL CerulenincellWall

0.696

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.634

EMB10-20 ug/mL EthambutolcellWall

1.101

Eta12-40 ug/mL EthionamidecellWall

1.374

INH0.2-0.4 ug/mL IsoniazidcellWall

0.830

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.746

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.153

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.919

BZA0.12 mg/mL BenzamidearomaticAmides

-0.432

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.239

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.455

H2O24 mM hydrogen peroxideDNAdamaging

0.681

Levo10 ug/mL LevofloxacinDNAdamaging

1.021

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.629

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.639

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.815

UVUV-irradiationDNAdamaging

-0.645

ARP41-4 ug/mL Antitubercular compound ARP4?

0.686

Antimycin12.5-50 ug/mL Antimycin A?

0.957

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.858

PA_110-50 ug/mL Antitubercular compound PA-1?

0.618

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.133

PA8240.2-2 ug/mL PA-824?

-0.910

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.162

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.509

Verapamil50 uM Verapamil?

0.624

mercaptoethanol2 mM 2-Mercaptoethanol?

0.950

methoxatin10-20 ug/mL Methoxatin?